Company Overview
General information about the Gilead Sciences company
Gilead Sciences is an American biopharmaceutical company that focuses on the development and commercialization of innovative medicines for the treatment of life-threatening diseases. The company was founded in 1987 and is headquartered in Foster City, California.
Gilead Sciences is known for its groundbreaking work in the field of HIV/AIDS. In 1996, the company launched its first HIV medication, Viread, which was the first of its kind to be approved by the US Food and Drug Administration (FDA). Since then, Gilead has developed and commercialized other HIV medications, including Truvada, Atripla, and Biktarvy.
In addition to its work in HIV/AIDS, Gilead Sciences has expanded into other areas of medicine, including hepatitis C, liver diseases, and oncology. In 2017, the company acquired Kite Pharma, a leader in the development of personalized cancer therapies, further diversifying its portfolio.
Gilead Sciences has a global presence, with operations in North America, Europe, Asia, and Latin America. The company currently employs over 12,000 people worldwide and has a market capitalization of over $90 billion.
In recent years, Gilead Sciences has faced criticism for the high prices of its medications, particularly for its HIV and hepatitis C treatments. The company has implemented various initiatives to increase access to its medicines for patients in need, including partnerships with generic drug manufacturers and patient assistance programs.
What is special about the Gilead Sciences company?
1. Pioneering Role in HIV/AIDS Treatment: Gilead Sciences played a crucial role in the development of antiretroviral drugs for the treatment of HIV/AIDS. Its first drug, Viread, was the first once-daily, single-tablet regimen for HIV treatment, which revolutionized HIV therapy.
2. Innovative Research and Development: The company has a strong focus on research and development and has a track record of bringing innovative therapies to the market. It has a robust pipeline of drugs in various stages of clinical development, including treatments for cancer, liver diseases, and inflammatory and respiratory conditions.
3. Groundbreaking Hepatitis C Treatment: Gilead's breakthrough drug, Sovaldi, was the first oral therapy for hepatitis C that offered a cure for the disease. It was also the fastest-selling drug in history, reaching $10 billion in sales within its first year of release.
4. Commitment to Access and Affordability: The company is committed to providing access to its life-saving medications to patients in need around the world. It has established numerous programs to make its medications accessible and affordable, including pricing agreements with various countries and a patient assistance program for uninsured and underinsured individuals in the United States.
5. Strong Financial Performance: Gilead Sciences has consistently delivered strong financial results, with a steady increase in revenue and earnings. Its financial stability allows the company to invest in research and development and diversify its portfolio.
6. Social Responsibility: The company is committed to making a positive impact beyond its products, with a focus on social responsibility and sustainability. It has initiatives to reduce its environmental footprint, promote diversity and inclusivity in its workforce, and support communities in need.
7. Corporate Culture: Gilead Sciences is known for its inclusive and supportive corporate culture, which promotes innovation, collaboration, and employee development. The company has been recognized with numerous awards for its workplace culture, including being named one of the best places to work for LGBTQ equality.
Interesting facts about the Gilead Sciences company
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the Gilead Sciences company's primary line of business?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the market opportunity of the Gilead Sciences company?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
SWOT analysis of the Gilead Sciences company
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
Porter's Five Forces analysis for the Gilead Sciences company
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the Gilead Sciences company's business model?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the Gilead Sciences company's unique selling proposition?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
How does the Gilead Sciences company differentiate itself in the market?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What are the Gilead Sciences company's potential challenges in the industry?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What challenges did the Gilead Sciences company face in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9DMno1Y010 Z1Z6T1RmTHNwaFFYSi53 ZWJwIiBhbHQ9IkdpbGVh ZCBTY2llbmNlcyIgdGl0 bGU9IkdpbGVhZCBTY2ll bmNlcyIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdpbGVh ZCBTY2llbmNlcz8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
